“…Approaches to relax myofibroblasts include: (1) specific interference with α-SMA in contractile stress fibers ; (2) inhibition of the Rho/Rho-associated kinase pathway that acts on myosin activity (Bond et al, 2011;Huang et al, 2011;Zhou et al, 2013); (3) interference with megakaryoblastic leukemia factor 1 (MKL1), also named myocardinrelated transcription factor (MRTF) that links mechanical stress via the polymerization state of actin to the transcriptional activity of muscle-cell genes in various myofibroblast precursor cells (Crider et al, 2011;Luchsinger et al, 2011;Scharenberg et al, 2014;Small et al, 2010;, and (4) interfering with YAP/TAZ transcription factors that mediate mechanoresponses (Halder et al, 2012) and positively regulate myofibroblast activation (Calvo et al, 2013;Liu et al, 2014;Speight et al, 2013;Talele et al, 2015). Rho kinase inhibitors were also used to inhibit myofibroblast activation from tenocytes, keratocytes, trabecular meshwork cells, and stromal fibroblasts (Anderson et al, 2004;Chen et al, 2009;Meyer-ter-Vehn et al, 2006;Pattabiraman et al, 2014;Petroll and Lakshman, 2015;Yamamoto et al, 2012).…”